As Tankyrase inhibitors have been shown to suppress tumor cell growth via inhibiting YAP [13–15], we investigated the effect of two Tankyrase inhibitors, XAV-939 and G007-LK, in regulating HCC cell growth. Here, TNKS is linked to hepatocellular carcinoma.